Early Magnetic Resonance Imaging Predicts 30-Month Outcomes after Therapeutic Hypothermia for Neonatal Encephalopathy.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 04 04 2021
revised: 02 06 2021
accepted: 01 07 2021
pubmed: 9 7 2021
medline: 24 11 2021
entrez: 8 7 2021
Statut: ppublish

Résumé

To evaluate the association of therapeutic hypothermia with magnetic resonance imaging (MRI) findings and 30-month neurodevelopment in term neonatal encephalopathy. Cross-sectional analysis of 30-month neurodevelopment (IQR 19.0-31.4) in a prospective cohort of mild-to-severe neonatal encephalopathy imaged on day 4 (1993-2017 with institutional implementation of therapeutic hypothermia in 2007). MRI injury was classified as normal, watershed, or basal ganglia/thalamus. Abnormal motor outcome was defined as Bayley-II psychomotor developmental index <70, Bayley-III motor score <85 or functional motor deficit. Abnormal cognitive outcome was defined as Bayley-II mental developmental index <70 or Bayley-III cognitive score <85. Abnormal composite outcome was defined as abnormal motor and/or cognitive outcome, or death. The association of therapeutic hypothermia with MRI and outcomes was evaluated with multivariable logistic regression adjusted for propensity to receive therapeutic hypothermia. Follow-up was available in 317 (78%) surviving children, of whom 155 (49%) received therapeutic hypothermia. Adjusting for propensity, therapeutic hypothermia was independently associated with decreased odds of abnormal motor (OR 0.15, 95% CI 0.06-0.40, P < .001) and cognitive (OR 0.11, 95% CI 0.04-0.33, P < .001) outcomes. This association remained statistically significant after adjustment for injury pattern. The predictive accuracy of MRI pattern for abnormal composite outcome was unchanged between therapeutic hypothermia-treated (area under the receiver operating curve 0.76; 95% CI 0.61-0.91) and untreated (area under the receiver operating curve 0.74; 95% CI 0.67-0.81) infants. The negative predictive value of normal MRI was high in therapeutic hypothermia-treated and untreated infants (motor 96% vs 90%; cognitive 99% vs 95%). Therapeutic hypothermia is associated with lower rates of brain injury and adverse 30-month outcomes after neonatal encephalopathy. The predictive accuracy of MRI in the first week of life is unchanged by therapeutic hypothermia. Normal MRI remains reassuring for normal 30-month outcome after therapeutic hypothermia.

Identifiants

pubmed: 34237346
pii: S0022-3476(21)00668-5
doi: 10.1016/j.jpeds.2021.07.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-101.e1

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Ashley M Bach (AM)

Departments of Neurology and Pediatrics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Department of Pediatrics, University of California-San Francisco, San Francisco, CA; Department of Neurology, University of California-San Francisco, San Francisco, CA.

Annie Y Fang (AY)

Department of Pediatric Hospital Medicine, Kaiser Permanente, Oakland, CA.

Sonia Bonifacio (S)

Department of Pediatrics, Stanford University, Palo Alto, CA.

Elizabeth E Rogers (EE)

Department of Pediatrics, University of California-San Francisco, San Francisco, CA.

Aaron Scheffler (A)

Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA.

J Colin Partridge (JC)

Department of Pediatrics, University of California-San Francisco, San Francisco, CA.

Duan Xu (D)

Department of Radiology, University of California-San Francisco, San Francisco, CA.

A James Barkovich (AJ)

Department of Radiology, University of California-San Francisco, San Francisco, CA.

Donna M Ferriero (DM)

Department of Pediatrics, University of California-San Francisco, San Francisco, CA; Department of Neurology, University of California-San Francisco, San Francisco, CA.

Hannah C Glass (HC)

Department of Pediatrics, University of California-San Francisco, San Francisco, CA; Department of Neurology, University of California-San Francisco, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, CA.

Dawn Gano (D)

Department of Pediatrics, University of California-San Francisco, San Francisco, CA; Department of Neurology, University of California-San Francisco, San Francisco, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH